- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 4, 2025 | 60.62M sh |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.26B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $1.16B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $7.87B |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $7.13B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $9.14B |
| Total Assets | Q3 2025 · Mar 31, 2024 | $8.3B |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $545.08M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2023 | $561.88M |
| Shares Diluted restated | Q3 2025 · Dec 31, 2023 | 59.29M sh |
| Shares Diluted restated | Q3 2025 · Dec 31, 2023 | 59.29M sh |
| Capex | Q3 2025 · Dec 31, 2023 | $36.27M |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$1.37B |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $1.63 |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | $4.73 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $1.65 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | $4.79 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $32.11M |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $86.21M |
| Net Income | Q3 2025 · Dec 31, 2023 | $96.37M |
| Net Income | Q3 2025 · Dec 31, 2023 | $280.32M |
| Revenue | Q3 2025 · Dec 31, 2023 | $418.63M |
| Revenue | Q3 2025 · Dec 31, 2023 | $1.17B |